• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习模型算法预测 5 年软组织黏液样脂肪肉瘤生存的研究进展。

Development of machine learning model algorithm for prediction of 5-year soft tissue myxoid liposarcoma survival.

机构信息

Department of Orthopedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Surg Oncol. 2021 Jun;123(7):1610-1617. doi: 10.1002/jso.26398. Epub 2021 Mar 8.

DOI:10.1002/jso.26398
PMID:33684246
Abstract

BACKGROUND

Predicting survival in myxoid liposarcoma (MLS) patients is very challenging given its propensity to metastasize and the controversial role of adjuvant therapy. The purpose of this study was to develop a machine-learning algorithm for the prediction of survival at five years for patients with MLS and externally validate it using our institutional cohort.

METHODS

Two databases, the surveillance, epidemiology, and end results program (SEER) database and an institutional database, were used in this study. Five machine learning models were created based on the SEER database and performance was rated using the TRIPOD criteria. The model that performed best on the SEER data was again tested on our institutional database.

RESULTS

The net-elastic penalized logistic regression model was the best according to our performance indicators. This model had an area under the curve (AUC) of 0.85 when compared to the SEER testing data and an AUC of 0.76 when tested against institutional database. An application to use this calculator is available at https://sorg-apps.shinyapps.io/myxoid_liposarcoma/.

CONCLUSION

MLS is a soft-tissue sarcoma with adjunct treatment options that are, in part, decided by prognostic survival. We developed the first machine-learning predictive algorithm specifically for MLS using the SEER registry that retained performance during external validation with institutional data.

摘要

背景

由于黏液样脂肪肉瘤(MLS)易发生转移,辅助治疗作用存在争议,因此预测 MLS 患者的生存情况极具挑战性。本研究旨在开发一种用于预测 MLS 患者五年生存率的机器学习算法,并使用我们的机构队列对其进行外部验证。

方法

本研究使用了两个数据库,即监测、流行病学和最终结果计划(SEER)数据库和机构数据库。基于 SEER 数据库创建了五个机器学习模型,并根据 TRIPOD 标准对性能进行了评估。在 SEER 数据上表现最好的模型再次在我们的机构数据库上进行了测试。

结果

根据我们的性能指标,净弹性罚 logistic 回归模型是最佳模型。与 SEER 测试数据相比,该模型的曲线下面积(AUC)为 0.85,与机构数据库相比,AUC 为 0.76。该计算器的应用程序可在 https://sorg-apps.shinyapps.io/myxoid_liposarcoma/ 上使用。

结论

MLS 是一种软组织肉瘤,辅助治疗方案部分取决于预后生存情况。我们使用 SEER 登记处开发了第一个专门针对 MLS 的机器学习预测算法,在使用机构数据进行外部验证时保留了性能。

相似文献

1
Development of machine learning model algorithm for prediction of 5-year soft tissue myxoid liposarcoma survival.机器学习模型算法预测 5 年软组织黏液样脂肪肉瘤生存的研究进展。
J Surg Oncol. 2021 Jun;123(7):1610-1617. doi: 10.1002/jso.26398. Epub 2021 Mar 8.
2
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?骨肿瘤研究组算法对软骨肉瘤患者 5 年生存率的预测在国际验证中的表现如何?
Clin Orthop Relat Res. 2020 Oct;478(10):2300-2308. doi: 10.1097/CORR.0000000000001305.
3
Prediction of 5-year survival in soft tissue leiomyosarcoma using a machine learning model algorithm.使用机器学习模型算法预测软组织平滑肌肉瘤的 5 年生存率。
J Surg Oncol. 2024 Mar;129(3):531-536. doi: 10.1002/jso.27514. Epub 2023 Nov 16.
4
Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?机器学习技术可用于预测软骨肉瘤患者的 5 年生存率吗?
Clin Orthop Relat Res. 2018 Oct;476(10):2040-2048. doi: 10.1097/CORR.0000000000000433.
5
Development of Machine Learning Algorithms for Prediction of 5-Year Spinal Chordoma Survival.用于预测5年脊索瘤生存率的机器学习算法的开发
World Neurosurg. 2018 Nov;119:e842-e847. doi: 10.1016/j.wneu.2018.07.276. Epub 2018 Aug 8.
6
Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.SORG 算法能否预测软骨肉瘤患者的 5 年生存率?一项外部验证。
Clin Orthop Relat Res. 2019 Oct;477(10):2296-2303. doi: 10.1097/CORR.0000000000000748.
7
Explainable machine learning predicts survival of retroperitoneal liposarcoma: A study based on the SEER database and external validation in China.可解释机器学习预测腹膜后脂肪肉瘤的生存:基于 SEER 数据库的研究和中国的外部验证。
Cancer Med. 2024 Jun;13(11):e7324. doi: 10.1002/cam4.7324.
8
Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.应用新型机器学习框架,利用监测、流行病学和最终结果(SEER)数据库预测男性非转移性前列腺癌特异性死亡率。
Lancet Digit Health. 2021 Mar;3(3):e158-e165. doi: 10.1016/S2589-7500(20)30314-9. Epub 2021 Feb 3.
9
Prognostic factors of patients with extremity myxoid liposarcomas after surgery.肢体黏液样脂肪肉瘤患者术后的预后因素。
J Orthop Surg Res. 2019 Mar 28;14(1):90. doi: 10.1186/s13018-019-1120-2.
10
Development and external validation of a machine learning model for prediction of survival in undifferentiated pleomorphic sarcoma.开发和外部验证用于预测未分化多形性肉瘤生存的机器学习模型。
Musculoskelet Surg. 2024 Mar;108(1):77-86. doi: 10.1007/s12306-023-00795-w. Epub 2023 Sep 1.

引用本文的文献

1
Advancing Prognostics in Oncology: Developing a Machine Learning Model for Predicting 2-Year and 5-Year Survival Rates in Patients with Undifferentiated Pleomorphic Sarcoma.肿瘤学中的预后进展:开发用于预测未分化多形性肉瘤患者2年和5年生存率的机器学习模型
Ann Surg Oncol. 2025 Sep 8. doi: 10.1245/s10434-025-18249-x.
2
Development and external validation of a machine learning model for prediction of survival in undifferentiated pleomorphic sarcoma.开发和外部验证用于预测未分化多形性肉瘤生存的机器学习模型。
Musculoskelet Surg. 2024 Mar;108(1):77-86. doi: 10.1007/s12306-023-00795-w. Epub 2023 Sep 1.
3
Myxoid Liposarcoma: How to Stage and Follow.
黏液样脂肪肉瘤:如何分期及随访
Curr Treat Options Oncol. 2023 Apr;24(4):292-299. doi: 10.1007/s11864-023-01064-5. Epub 2023 Mar 3.